1. Home
  2. ASTS vs TLX Comparison

ASTS vs TLX Comparison

Compare ASTS & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASTS
  • TLX
  • Stock Information
  • Founded
  • ASTS 2019
  • TLX 2015
  • Country
  • ASTS United States
  • TLX Australia
  • Employees
  • ASTS N/A
  • TLX N/A
  • Industry
  • ASTS Telecommunications Equipment
  • TLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASTS Consumer Discretionary
  • TLX Health Care
  • Exchange
  • ASTS Nasdaq
  • TLX Nasdaq
  • Market Cap
  • ASTS 6.3B
  • TLX 5.7B
  • IPO Year
  • ASTS N/A
  • TLX N/A
  • Fundamental
  • Price
  • ASTS $45.94
  • TLX $17.15
  • Analyst Decision
  • ASTS Strong Buy
  • TLX Strong Buy
  • Analyst Count
  • ASTS 6
  • TLX 2
  • Target Price
  • ASTS $44.08
  • TLX $22.00
  • AVG Volume (30 Days)
  • ASTS 16.0M
  • TLX 24.4K
  • Earning Date
  • ASTS 08-13-2025
  • TLX 01-01-0001
  • Dividend Yield
  • ASTS N/A
  • TLX N/A
  • EPS Growth
  • ASTS N/A
  • TLX 798.14
  • EPS
  • ASTS N/A
  • TLX 0.09
  • Revenue
  • ASTS $4,636,000.00
  • TLX $484,687,790.00
  • Revenue This Year
  • ASTS $1,331.30
  • TLX N/A
  • Revenue Next Year
  • ASTS $370.72
  • TLX N/A
  • P/E Ratio
  • ASTS N/A
  • TLX $189.97
  • Revenue Growth
  • ASTS 827.20
  • TLX 55.85
  • 52 Week Low
  • ASTS $9.32
  • TLX $13.61
  • 52 Week High
  • ASTS $48.94
  • TLX $30.36
  • Technical
  • Relative Strength Index (RSI)
  • ASTS 82.61
  • TLX N/A
  • Support Level
  • ASTS $22.47
  • TLX N/A
  • Resistance Level
  • ASTS $42.93
  • TLX N/A
  • Average True Range (ATR)
  • ASTS 2.96
  • TLX 0.00
  • MACD
  • ASTS 1.51
  • TLX 0.00
  • Stochastic Oscillator
  • ASTS 88.56
  • TLX 0.00

About ASTS AST SpaceMobile Inc.

AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building a cellular broadband network in space to operate directly with standard, unmodified mobile devices, and off-the-shelf mobile phones based on extensive IP and patent portfolio. It has focused on eliminating the connectivity gaps faced by mobile subscribers. The Company's spaceMobile Service is being designed to provide cost-effective, high-speed Cellular Broadband services to end-users who are out of terrestrial cellular coverage using existing mobile devices.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: